Fermer le menu

Member of Lyonbiopole


DicarTech is developing an innovative non-invasive diagnostic medical device for intensive care, pediatry, emergency physicians. DiCART measures the tissue perfusion for patients in severe circulatory failure. Critical situation which, without treatment, can lead to multi-organ failure, lethal situation. DiCART enables reliable, accurate rapid diagnosis to objectively appreciate the efficiency of the therapies involved. Replaces manual and visual assessments, imprecise


Strategic application domain: Human Medicine

Application market: Cardiology

Type of activity: Medical device

Created on june 1st, 2018 - 2 employees



28 chem des Pilles 07100 Annonay



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.